Chia‐Lun Wu

509 total citations
24 papers, 377 citations indexed

About

Chia‐Lun Wu is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Chia‐Lun Wu has authored 24 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Surgery and 6 papers in Cancer Research. Recurrent topics in Chia‐Lun Wu's work include Bladder and Urothelial Cancer Treatments (6 papers), Epigenetics and DNA Methylation (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Chia‐Lun Wu is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Epigenetics and DNA Methylation (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Chia‐Lun Wu collaborates with scholars based in Taiwan, Canada and Germany. Chia‐Lun Wu's co-authors include Dah‐Shyong Yü, Jar‐Yi Ho, Sheng‐Chieh Chou, Cheng‐Ping Yu, Ching‐Wei Yang, Shun‐Hsing Hung, Kun‐Hung Shen, Wei‐Chieh Weng, Sheng‐Tang Wu and Yi‐Chia Wei and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Phytochemistry.

In The Last Decade

Chia‐Lun Wu

24 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chia‐Lun Wu Taiwan 13 184 88 67 46 45 24 377
Louis Villeneuve Canada 12 269 1.5× 57 0.6× 65 1.0× 43 0.9× 39 0.9× 26 702
Peace Mabeta South Africa 10 197 1.1× 58 0.7× 55 0.8× 26 0.6× 105 2.3× 23 383
Robert Roth Sweden 13 315 1.7× 55 0.6× 33 0.5× 56 1.2× 47 1.0× 23 511
Xiaoyan Xuan China 12 282 1.5× 130 1.5× 36 0.5× 42 0.9× 85 1.9× 29 415
Elena Palma United Kingdom 13 372 2.0× 86 1.0× 64 1.0× 33 0.7× 55 1.2× 23 634
Song‐Bin Guo China 11 167 0.9× 71 0.8× 37 0.6× 42 0.9× 77 1.7× 23 354
Maria Magdalena Barreca Italy 10 331 1.8× 194 2.2× 43 0.6× 59 1.3× 44 1.0× 15 524
Sasikumar J. Soumya India 5 246 1.3× 83 0.9× 40 0.6× 49 1.1× 54 1.2× 8 440
Zhongqi Li China 13 222 1.2× 89 1.0× 45 0.7× 44 1.0× 159 3.5× 20 520
Benyan Zhang China 12 164 0.9× 68 0.8× 82 1.2× 68 1.5× 96 2.1× 38 502

Countries citing papers authored by Chia‐Lun Wu

Since Specialization
Citations

This map shows the geographic impact of Chia‐Lun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Lun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Lun Wu more than expected).

Fields of papers citing papers by Chia‐Lun Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chia‐Lun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Lun Wu. The network helps show where Chia‐Lun Wu may publish in the future.

Co-authorship network of co-authors of Chia‐Lun Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chia‐Lun Wu. A scholar is included among the top collaborators of Chia‐Lun Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chia‐Lun Wu. Chia‐Lun Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yi‐Hsiang, Chia‐Lun Wu, Wei‐Chieh Weng, & Yi‐Chia Wei. (2025). Predictors of the Short‐Term Outcomes of Guillain–Barré Syndrome: Exploring Electrodiagnostic and Clinical Features. Brain and Behavior. 15(1). e70257–e70257. 1 indexed citations
2.
Wu, Chia‐Lun, et al.. (2024). 52243 AH-001: An Emerging Androgen Receptor Degrader Showing Therapeutic Potential in Addressing Androgenetic Alopecia (AGA). Journal of the American Academy of Dermatology. 91(3). AB119–AB119. 2 indexed citations
3.
Michell‐Robinson, Mackenzie A., Kristin E. Noack Watt, Maxime Pinard, et al.. (2023). Hypomyelination, hypodontia and craniofacial abnormalities in a Polr3b mouse model of leukodystrophy. Brain. 146(12). 5070–5085. 5 indexed citations
4.
Wu, Chia‐Lun, et al.. (2022). The Study of 3D Printing-Assisted Electrospinning Technology in Producing Tissue Regeneration Polymer-Fibroin Scaffold for Ureter Repair. SHILAP Revista de lepidopterología. 48(2). 118–129. 6 indexed citations
5.
6.
Liaw, Chia‐Ching, Hung‐Tse Huang, Hui‐Kang Liu, et al.. (2021). Cucurbitane-type triterpenoids from the vines of Momordica charantia and their anti-inflammatory, cytotoxic, and antidiabetic activity. Phytochemistry. 195. 113026–113026. 6 indexed citations
7.
Wu, Chia‐Lun, et al.. (2021). Evaluation of Intensified Colorectal Cancer Treatment Using Model Based on Delphi Method, Fuzzy Logic, and Analytical Hierarchy Process (DFAHP). Sensors and Materials. 33(10). 3499–3499. 3 indexed citations
8.
Huang, Hung‐Tse, Lijie Zhang, Hui‐Chi Huang, et al.. (2020). Cucurbitane-Type Triterpenoids from the Vines of Momordica charantia and Their Anti-inflammatory Activities. Journal of Natural Products. 83(5). 1400–1408. 17 indexed citations
9.
Yang, Ching‐Wei, Chia‐Lun Wu, Jar‐Yi Ho, et al.. (2019). The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol. Oncology Letters. 18(6). 6869–6876. 33 indexed citations
10.
Wu, Chia‐Lun, Jar‐Yi Ho, Shun‐Hsing Hung, & Dah‐Shyong Yü. (2018). miR‐429 expression in bladder cancer and its correlation with tumor behavior and clinical outcome. The Kaohsiung Journal of Medical Sciences. 34(6). 335–340. 19 indexed citations
11.
Wu, Chia‐Lun, Chun‐Liang Chen, Hsu‐Shan Huang, & Dah‐Shyong Yü. (2018). A new niclosamide derivatives‐B17 can inhibit urological cancers growth through apoptosis‐related pathway. Cancer Medicine. 7(8). 3945–3954. 6 indexed citations
12.
Wu, Chia‐Lun, et al.. (2016). Evasion of Cell Senescence Leads to Medulloblastoma Progression. Cell Reports. 14(12). 2925–2937. 31 indexed citations
13.
Wu, Chia‐Lun, Jar‐Yi Ho, Sheng‐Chieh Chou, & Dah‐Shyong Yü. (2016). MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer. Oncotarget. 7(18). 26593–26603. 63 indexed citations
14.
Yü, Dah‐Shyong, et al.. (2016). Comparison of therapeutic efficacy of lipo-doxorubicin and doxorubicin in treating bladder cancer. Urological Science. 28(4). 200–205. 8 indexed citations
15.
Yü, Dah‐Shyong, et al.. (2015). Bacille Calmette‐Guerin can induce cellular apoptosis of urothelial cancer directly through toll‐like receptor 7 activation. The Kaohsiung Journal of Medical Sciences. 31(8). 391–397. 36 indexed citations
16.
Wu, Chia‐Lun, et al.. (2011). Tyrosine kinase receptor inhibitor‐targeted combined chemotherapy for metastatic bladder cancer. The Kaohsiung Journal of Medical Sciences. 28(4). 194–203. 14 indexed citations
17.
Yü, Dah‐Shyong, et al.. (2011). The Feasibility of BCG and Sunitinib Combination Therapy for Transitional Cell Carcinoma. Urological Science. 22(1). 19–27. 2 indexed citations
18.
Wu, Chia‐Lun, et al.. (2010). Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway. Urologic Oncology Seminars and Original Investigations. 30(5). 652–659. 13 indexed citations
19.
Wu, Chia‐Lun, et al.. (2010). An automated vulnerability scanner for injection attack based on injection point. 113–118. 21 indexed citations
20.
Huang, Wen‐Yi, Yu-Yi Chien, Chia‐Lun Wu, et al.. (2009). Pituitary adenoma apoplexy with initial presentation mimicking bacterial meningoencephalitis: a case report. The American Journal of Emergency Medicine. 27(4). 517.e1–517.e4. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louis Villeneuve Breakdown of academic impact, for papers by Peace Mabeta Breakdown of academic impact, for papers by Robert Roth Breakdown of academic impact, for papers by Xiaoyan Xuan Breakdown of academic impact, for papers by Elena Palma Breakdown of academic impact, for papers by Song‐Bin Guo Breakdown of academic impact, for papers by Maria Magdalena Barreca Breakdown of academic impact, for papers by Sasikumar J. Soumya Breakdown of academic impact, for papers by Zhongqi Li Breakdown of academic impact, for papers by Benyan Zhang
Rankless by CCL
2026